Pharmaceutical Executive February 5, 2025
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI compares and discusses the potential impact of AI-driven drug discovery platforms.
In this interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses the potential impact of AI-driven drug discovery platforms like DeepSeek and Qwen, highlighting their democratizing potential while also acknowledging challenges related to data quality and validation. The conversation explores the potential disruptions to current R&D practices, including the acceleration of drug discovery and the optimization of manufacturing and supply chains.
The discussion also addresses the potential risks associated with relying heavily on open-access AI models, including data security, intellectual property concerns, and the potential for biases in underlying datasets. Finally, the interview touches...
Today's Sponsors
Today's Sponsor